Whitehawk Therapeutics, Inc. (WHWK) Tops Q3 EPS by 22c

Whitehawk Therapeutics, Inc. (NASDAQ: WHWK) reported Q3 EPS of ($0.26), $0.22 better than the analyst estimate of ($0.48).

For earnings history and earnings-related data on Whitehawk Therapeutics, Inc. (WHWK) click here.

You May Also Be Interested In

• UBS Starts Kalyan Jewellers India Ltd (KALYANKJ:IN) at Buy
• Corning (GLW) files for up to $2B offering of common shares
• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh